Castuner
Dodaj podcast

Keeping Current

Medscape Podcasts

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Strona podcastu

Słuchaj w swojej aplikacji

Odcinki

634 odcinki

  1. European Alzheimer's Care: A Live, Case-Based Forum on Amyloid-Targeting Therapy 55:04
  2. Deciphering Clinical Data in Transthyretin Cardiac Amyloidosis for Today's Clinical Practice 31:14
  3. Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer 28:14
  4. Navigating IgA Nephropathy Management in an Evolving Treatment Landscape: Key Considerations for Treatment Selection 45:43
  5. Antibody-Drug Conjugate Therapy for Early Breast Cancer: Innovations That Shape the Future of Care 31:56
  6. Solving the Alzheimer's Disease Biomarker Puzzle: Live, European Peer Workshop 36:28
  7. Advancing Uveitic Macular Edema Management: What's New? 32:09
  8. Patient Journeys With IgA Nephropathy: Optimizing Outcomes in Patient Care 59:36
  9. Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era 52:11
  10. The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases: Exploring the Potential for CAR T-Cell Therapies 48:44
  11. Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer 35:38
  12. Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health 29:23
  13. The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis 42:15
  14. Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start 47:35
  15. Myasthenia Gravis Guidelines: A Global View for Local Practice 38:12
  16. From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic 18:01
  17. Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring 41:36
  18. Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late? 39:21
  19. Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key Data 27:56
  20. Beyond Intervals: The Next Era of Continuous Delivery in Retinal Medicine 32:28
  21. When and How Should I Optimize Heart Failure Treatments for My Patients? 26:07
  22. The Evolving Diagnostic and Management Landscape for Progressive Familial Intrahepatic Cholestasis 35:35
  23. Pharmacological and Combination Interventions for Nicotine Cessation 33:24
  24. Is Normalizing Hemostasis an Achievable Goal in Hemophilia A? 29:31
  25. The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management 17:41
  26. Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice 37:03
  27. Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies 23:21
  28. Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors 21:55
  29. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes 26:15
  30. The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement 29:13
  31. Depression and Neurological Diseases: What's the Link? 22:29
  32. What Lies Beneath Generalized Myasthenia Gravis: Exploring Novel Mechanisms of Action of Emerging Therapies 31:16
  33. Charting New Frontiers in Advanced Breast Cancer: Milestones, Missions, and Mastery 1:16:10
  34. Beyond SGLT2: The Emerging Role of Dual SGLT1/2 Inhibition in Heart Failure 29:49
  35. Addressing Unmet Needs in the Management of Sjögren's Disease: A Spotlight on Emerging Biologic Therapies 30:40
  36. Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia 35:33
  37. Diabetic Macular Edema: Express Q&A on What's New 16:57
  38. The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure 17:14
  39. Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach 21:05
  40. Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer 36:15
  41. New Horizons in Uveitic Macular Edema 33:32
  42. Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis 51:20
  43. Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines 37:09
  44. Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers 31:04
  45. Avoiding Common Mistakes in Managing Focal Epilepsy 19:08
  46. From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance 35:16
  47. The CLL Consultation: Partnering With Patients for Person-Centred Care 35:34
  48. Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates 37:26
  49. Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence 33:46
  50. 2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer 36:58